Breast Lift in LV
Breast Lift in LV section, includes general infrmation about Breast Lift Procedure, Breast Lift LV Local News, Breast Lift LV Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift LV (current)
LV Breast Reduction
LV Breast Implants
LV Implant Removal
LV Armpit Incision
More LV info...
Latvia Understand Cesis castle in Vidzeme regionLatvia is a famous ancient trading point. The famous ‘route from the Vikings to the Greeks’ mentioned in ancient chronicles stretched from Scandinavia through Latvian territory along the river Daugava to the Ancient Russia and Byzantine Empire.
Across the European continent, Latvia’s coast was known as a place for obtaining amber. In the Middle Ages amber was more valuable than gold in many places. Latvian amber was known in places as far away as Ancient Greece and the Roman Empire.
At the 12th century, German traders arrived, bringing with them missionaries who attempted to convert the pagan Baltic and Finno-Ugrian tribes to the Christian faith.
Latvia Regions Map of Latvia Statue of Rolands, Riga Old TownThere are four historical regions of Latvia:
Plastic Surgery News...
- According to BioSpace, preliminary results from a Phase III study evaluating Sativex® in the treatment of Multiple Sclerosis (MS)-related pain, show that it failed to meet its primary endpoint.
The double-blind, placebo-controlled study involved 339 patients with central neuropathic pain due to MS, who had achieved inadequate pain relief with existing therapies. The primary endpoint was the proportion of patients whose pain was reduced by at least 30% (using 0-10 numerical scale) – although this was achieved by 50% of patients randomised to Sativex, this was not found to be statistically significantly different from placebo due to an unexpectedly large placebo response [the placebo response rate is not stated in the news item].
The BioSpace article notes that patients were able to self-administer the spray at will, and that this ‘may have confounded the overall comparison’ as those in the placebo group took significantly more doses overall. This was however designed to reflect the ‘real world’ use of Sativex as much as possible, whereby patients initially experiment with dosing of Sativex to find their optimum dose level. GW made the decision last year to adopt a fixed target dose approach for the ongoing studies in cancer pain and MS spasticity. Following a comprehensive review of this data, GW intends to carry out a further study in this patient population.
- ZIOPHARM Oncology, Inc.